Brain (and spinal cord) tumours
Results
Phase 1
This trial was looking at a new vaccine called IMA950 for people with a type of brain tumour called glioblastoma multiforme. The trial was supported by Cancer Research UK.
Recruitment start: 9 September 2010
Recruitment end: 18 February 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Roy Rampling
Cancer Research UK (Centre for Drug Development)
Experimental Cancer Medicine Centre (ECMC)
Immatics Biotechnologies GmbH
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUKD/10/045.
Last reviewed: 4 November 2015
CRUK internal database number: 5031
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
